BCDA — BIOCARDIA INC

Ownership history in BROWN ADVISORY INC  ·  23 quarters on record

This page tracks every 13F SEC filing in which BROWN ADVISORY INC reported a position in BIOCARDIA INC (BCDA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 35,538 — 0% 0.00% $44K $1.25
2025 Q3 UNCHANGED 35,538 — 0% 0.00% $46K $1.29
2025 Q2 UNCHANGED 35,538 — 0% 0.00% $69K $1.95
2025 Q1 ADDED 35,538 +2,453 +7.4% 0.00% $90K $2.54
2024 Q1 UNCHANGED 33,085 — 0% 0.00% $13K $6.15
2023 Q4 UNCHANGED 33,085 — 0% 0.00% $22K $9.90
2023 Q3 UNCHANGED 33,085 — 0% 0.00% $14K $6.45
2023 Q2 UNCHANGED 33,085 — 0% 0.00% $88K $40.05
2023 Q1 UNCHANGED 33,085 — 0% 0.00% $65K $29.25
2022 Q4 UNCHANGED 33,085 — 0% 0.00% $69K $31.35
13 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    BCDA price (monthly, adj. close)

Other funds also holding BCDA

As of 2025 Q4 — sorted by position size

CM Management, LLC 3Y 0.14% Pingora Partners LLC 0.0% DRW Securities, LLC 3Y 7Y 0.0% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.0% XTX Topco Ltd 3Y 0.0% Tower Research Capital LLC (TRC) 3Y 7Y 0.0% WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 3Y 7Y 0.0% COMMONWEALTH EQUITY SERVICES, LLC 3Y 7Y 0.0% TWO SIGMA INVESTMENTS, LP 3Y 7Y 0.0% CITADEL ADVISORS LLC 3Y 7Y 0.0%
← Back to BROWN ADVISORY INC Holdings